NYSE$MPT
Medical Properties Trust Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Reported net income of $0.19 per share and normalized FFO of $0.43 per share.
Medical Properties Trust reported strong second-quarter results with a net income of $0.19 per share and normalized FFO of $0.43 per share. The company continued to execute accretive acquisitions and strategic investments in healthcare facilities.
- Net income of $0.19 and Normalized Funds from Operations (“NFFO”) of $0.43 for the 2021 second quarter on a per diluted share basis, in line with portfolio run-rate guidance.
- Closed in late June on previously announced sale-leaseback transactions totaling £800 million on 35 Priory Group (“Priory”) behavioral health facilities in the United Kingdom, with proceeds used to fully retire the initial January real estate loan investment of the same amount.
- Completed in early July the $215 million acquisition of four general acute care hospitals operated by Pipeline Health System (“Pipeline Health”) in Los Angeles.
- Agreed to invest $950 million in behavioral health assets of Springstone, LLC (“Springstone”), including full ownership of 18 inpatient behavioral hospital facilities and an interest in the operations, and to acquire five general acute care hospitals in South Florida to be operated by Steward Health Care System (“Steward”) for $900 million.
Headline financials
Revenue & EPS history
Medical Properties Trust · Revenue · Quarterly
$382M
Revenue by segment
Medical Properties Trust · $382M total across 4 segments · Q2 2021
- Rent Billed$217M+25.0%56.8%
- Interest and Other Income$59.1M+32.4%15.5%
- Straight-line Rent$55.5M+162.2%14.5%
- Income from Financing Leases$50.3M-4.1%13.2%
Forward guidance
MPT expects an annual run-rate of $1.14 to $1.18 per diluted share for net income and $1.72 to $1.76 per diluted share for NFFO.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
+1.3%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+0.7%
Avg return
30 days after
65%
42 / 65 earnings
Positive
+17.0%
Q4 2024
Best reaction
-15.8%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.6% | -4.1% | -6.0% | |
| Q4 2025 | +12.1% | +6.1% | -15.1% | |
| Q3 2025 | +6.6% | +1.4% | +18.5% | |
| Q1 2025 | -6.9% | -8.0% | -17.2% | |
| Q4 2024 | +17.0% | +18.2% | +26.6% | |
| Q3 2024 | +7.0% | -5.2% | -9.8% | |
| Q2 2024 | +1.5% | +2.4% | +7.4% | |
| Q1 2024 | +7.2% | +31.2% | +20.4% | |
| Q4 2023 | +2.5% | +6.7% | +13.9% | |
| Q3 2023 | +9.9% | +7.2% | +4.7% | |
| Q2 2023 | -15.8% | -20.0% | -33.4% | |
| Q1 2023 | +10.6% | +4.9% | -0.1% | |
| Q4 2022 | -13.5% | -15.6% | -38.3% | |
| Q3 2022 | +6.8% | +6.5% | +20.6% | |
| Q2 2022 | -5.3% | -4.3% | -15.3% | |
| Q1 2022 | +4.1% | +6.3% | +5.2% | |
| Q4 2021 | -4.0% | -5.2% | -10.2% | |
| Q3 2021 | +0.1% | -1.2% | +1.5% | |
| Q2 2021 | +1.3% | -1.5% | -3.3% | |
| Q1 2021 | -2.0% | -4.1% | -5.9% | |
| Q4 2020 | +0.0% | +1.6% | -2.9% | |
| Q3 2020 | +3.7% | +10.9% | +13.8% | |
| Q2 2020 | -0.8% | -1.6% | -8.5% | |
| Q1 2020 | +4.1% | +0.5% | +9.8% | |
| Q4 2019 | +2.3% | +3.6% | +1.1% | |
| Q3 2019 | +1.2% | -6.8% | +0.9% | |
| Q2 2019 | +2.1% | -0.1% | +6.2% | |
| Q1 2019 | +3.8% | +1.2% | +2.0% | |
| Q4 2018 | +3.4% | +1.7% | +1.1% | |
| Q3 2018 | +3.2% | +9.9% | +16.2% | |
| Q2 2018 | +1.0% | +3.0% | +4.2% | |
| Q1 2018 | +1.8% | +2.0% | +5.6% | |
| Q4 2017 | +1.6% | +1.5% | +6.6% | |
| Q3 2017 | +3.2% | +3.9% | +4.8% | |
| Q2 2017 | -1.7% | +0.1% | +5.2% | |
| Q1 2017 | +2.1% | +2.5% | +4.3% | |
| Q4 2016 | +1.8% | +1.8% | -6.3% | |
| Q3 2016 | -0.8% | +1.3% | -2.7% | |
| Q2 2016 | +1.1% | +2.0% | -0.5% | |
| Q1 2016 | +3.8% | — | — | |
| Q4 2015 | -2.5% | — | — | |
| Q3 2015 | -3.4% | — | — | |
| Q2 2015 | -3.8% | — | — | |
| Q1 2015 | +2.9% | — | — | |
| Q4 2014 | +0.4% | — | — | |
| Q3 2014 | +2.7% | — | — | |
| Q2 2014 | -0.3% | — | — | |
| Q1 2014 | -0.9% | — | — | |
| Q4 2013 | -0.4% | — | — | |
| Q3 2013 | -0.7% | — | — | |
| Q2 2013 | -2.8% | — | — | |
| Q1 2013 | -1.0% | — | — | |
| Q4 2012 | +1.1% | — | — | |
| Q3 2012 | +3.1% | — | — | |
| Q2 2012 | +0.7% | — | — | |
| Q1 2012 | -0.1% | — | — | |
| Q4 2011 | -0.6% | — | — | |
| Q4 2009 | -0.6% | — | — | |
| Q3 2011 | -4.4% | — | — | |
| Q2 2011 | +4.5% | — | — | |
| Q1 2011 | +2.8% | — | — | |
| Q4 2010 | +2.8% | — | — | |
| Q3 2010 | +0.5% | — | — | |
| Q2 2010 | +1.0% | — | — | |
| Q1 2010 | +7.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro